Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

Multiple SclerosisClinically Isolated SyndromeNMO Spectrum Disorder+2 more
icometrix7,000 enrolled3 locationsNCT06280755
Recruiting

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

EpilepsyMultiple SclerosisAlzheimer Disease+7 more
Assistance Publique Hopitaux De Marseille700 enrolled1 locationNCT07202494
Recruiting

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Multiple SclerosisOptic NeuritisTransverse Myelitis+15 more
University of Bern500 enrolled13 locationsNCT05017142
Recruiting
Early Phase 1

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

Myasthenia GravisAutoimmune EncephalitisMultiple Sclerosis+7 more
Tongji Hospital36 enrolled1 locationNCT04561557
Recruiting
Not Applicable

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)

Multiple SclerosisAcute Disseminated EncephalomyelitisNeuromyelitis Optica Spectrum Disorder+2 more
Tongji Hospital250 enrolled1 locationNCT06474520
Recruiting

Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases

Clinically Isolated SyndromeAcute Disseminated EncephalomyelitisMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+3 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University450 enrolled1 locationNCT06541626
Recruiting

National, Multicentric Registry Study on Neuroimmunological Diseases in China

Myasthenia GravisAutoimmune EncephalitisMultiple Sclerosis+3 more
Xuanwu Hospital, Beijing7,000 enrolled1 locationNCT06443333
Recruiting

MS-ResearchBiomarkerS

Neurologic DisorderMultiple SclerosisClinically Isolated Syndrome+8 more
Cedars-Sinai Medical Center1,000 enrolled1 locationNCT05204459